ABSTRACT
INTRODUCTION
Obesity is a chronic metabolic disorder that often results from increase in energy intake or decrease in energy expenditure or a combination of both [1] . According to the World Health Organization (WHO) in 2005, there were about 1.6 billion overweight individuals worldwide [2] . A major concern with obesity is cardio metabolic risk frequently associated with atherosclerotic cardiovascular disease or diabetes mellitus. Obesity brings about alteration in adipose tissue metabolism and is associated with release of hormones and peptides that contribute to the complications of obesity including metabolic syndrome, type 2 DM and cardiovascular disease [1] .
Obesity, especially abdominal (visceral), measured as Waist Circumference, is associated with chronic low grade inflammation characterized by cytokine production and increased acute phase reactants. The adipose tissue in obesity is infiltrated by macrophages as well, which are an important source of inflammation [3] . Various inflammatory mediators released from adipose tissue play an important role in endothelial dysfunction by direct or indirect actions on the vascular endothelium [3] . Urinary albumin excretion especially in the microalbuminuric range (30 -300 mg/g creatinine) may represent an early sign of widespread derangement of endothelial function inducing an atherosclerotic process [4] . In hypertension and diabetes increased rate of albumin excretion is associated with high risk of cardiovascular morbidity and mortality. Slightly elevated urinary albumin excretion rate in microalbuminuric range has been reported to predict increased cardiovascular morbidity and mortality even in nondiabetic subjects [5] . In patients with metabolic syndrome which includes insulin resistance, diabetes mellitus, hypertension, dyslipidemia and obesity, microalbuminuria is considered as a marker of endothelial dysfunction [6] . This study was undertaken to observe whether or not microalbuminuria is present in obese individuals without DM and hypertension.
MATERIALS AND METHODS
The study was conducted on patients attending the outpatient health check-up clinic at M S Ramaiah Memorial Hospital, Bangalore, India. The study was conducted after taking the required Ethical clearance from the ethical review board and all patients who signed the informed consent participated in the study. Two groups of non-diabetic normotensive adult individuals in the age group of 20 -60 yrs were selected. Group Anthropometric indices such as BMI (body weight in Kg/height in m 2 ) and Waist circumference (WC) in cm were recorded in both the groups. WC was evaluated as the minimum circumference between xiphoid process and umbilicus. Cut off points for obese subjects were BMI > 23 kg/m 2 and WC ≥ 80 cm for females and ≥90 cm for males as per WHO standards for Asians [7] . Around 5 ml of spot urine sample in a sterile container was collected for determination of spot urinary albumin excretion and urinary creatinine. Urinary albumin excretion was calculated as urinary albumin creatinine ratio (UACR). Blood samples after 10 -12 hours of overnight fasting was collected for estimation of fasting blood glucose & complete lipid profile. Estimation of urinary albumin was carried out by immunoturbidimetric assay Tina-quant Albumin Gen.2 kit (Roche Diagnostics Indianapolis USA cat. No. 0449658 190) method [8] and urinary creatinine was estimated by Buffered kinetic jaffes reaction without deproteinization, Creatinine Jaffe Gen. 2 kit (Roche Diagnostics Indianapolis USA cat. No. 04810716 190) method [9] . UACR was calculated as mg of albumin/g of creatinine. Blood glucose was assayed by Hexokinase kit (Siemens Healthcare Diagnostics Ltd., Frimely, Camberley, UK cat. No. DF40) method [10] . Serum total cholesterol by enzymatic kit (Siemens Healthcare Diagnostics Ltd. Frimely, Camberley, UK cat. No. DF27) method [11] , serum triglyceride by enzymatic kit (Siemens Healthcare Diagnostics Ltd. Frimely, Camberley, UK cat. No. DC 6A) method [12] and serum HDL by accelerator selective detergent kit (Siemens Healthcare Diagnostics Ltd. Frimely, Camberley, UK cat. No. DF 48B) method [13] . Serum LDL and VLDL were calculated from the estimated values of cholesterol, triglyceride and HDL, using the equation of Frieldwald et al. [14] 
STATISTICAL ANALYSIS
Statistical analysis was performed using t-test and Pearson's correlation in SPSS 12.0 for Windows Program.
RESULTS & DISCUSSION
Results are shown in Tables 1-6. BMI and WC were significantly high in cases compared to controls as shown in Table 1. Table 2 shows the urinary albumin levels in the cases and controls. The urinary albumin levels in cases showed a mean ± SD of 2.34 ± 2.56 and 1.71 ± 2.10 in controls with "p" value of 0.22, which was not significant. Both the cases and controls were divided depending on the urinary albumin levels into 3 categories viz 0 -5, >5 up to 10 and >10 mg/g creatinine. However, urinary albumin excretion was not observed in the microalbuminuric range of ACR (Albumin Creatinine Ratio) 30 -300 mg/g in spot urine samples of both cases and controls irrespective of the lipid profile values. In a study by valensi et al, daily urine albumin excretion was significantly higher in obese people than lean people with prevalence of microalbuminuria in non diabetic obese people [15] .
No positive correlation was observed between urinary albumin levels with anthropometric indices i.e. BMI & waist circumference as shown in Table 3 . These findings are similar to a study made by Tijen Erdem Yesim et al., where microalbuminuria was not detected in obese women without DM and hypertension and urinary albumin excretion was similar in obese and lean women [4] . In the present study, only those cases that had familial hyperlipidemia were excluded by history taking. During the course of the study, it was observed that there were a few individuals in the controls as well as in the cases who exhibited abnormal lipid profile as shown in Table 4 In a cross sectional analysis of 1160 cases of type 1 diabetes mellitus, progressive increase in albuminuria was associated with elevations in proatherogenic LDL. In addition, this study also revealed that in patients of essential hypertension with/without DM, microalbuminuria was associated with low HDL and increased serum total cholesterol. The most consistent association between lipoprotein abnormalities and microalbuminuria is low HDL cholesterol which suggests that clearance of LDL cholesterol may be as important as low levels of HDL to avoid cellular injury. Thus, apparent association between microalbuminuria and cardiovascular disease may be related to this adverse risk factor profile [16] . Previous reports show that the presence of microalbuminuria and macroalbuminuria is associated with high risk of CVD incidence and mortality in high risk individuals like patients with hypertension and DM. Furthermore, investigators have reported that microalbuminuria predicts CVD and mortality rates in community based samples [17] . The beginning of endothelial dysfunction and there by atherosclerosis, is multi factorial. Factors such as hyperglycemia, insulin resistance, procoagulant state and adhesion molecules may also play their part in the above mentioned pathology. While these factors can be accepted as contributors for MAU in diabetic patients, in nondiabetic normotensive obese individuals collective factors may not converge and give rise to wide-spread endothelial dysfunction and microalbuminuria [18] . However, a recent community based follow up study (median follow up 6 years) by Johan Arlov et al. in 1568 nondiabetic normotensive individuals revealed that participants with urinary ACR greater than or equal to the sex specific median (≥3.9 mg/g for men, ≥7.5 mg/g for women) in a single void sample experienced nearly a threefold risk of CVD and a borderline significantly increased risk of death compared with those with urinary ACR below the median there by predicting the development of CVD with low levels of urinary albumin excretion well below the current microalbuminuric threshold. The study contemplates lowering of the established microalbuminuric range for predicting risk of CVD [19] . The present study also has reflected the fact that urinary albumin levels in nondiabetic normotensive obese individuals are much lesser than the established microalbuminuric range. This pilot study can be extended into a follow up study on a larger population observing the number of cases progressing to CVD. If the observation shows normotensive nondiabetic obese individuals progressing to cardiovascular disease, perhaps, the idea of modifying and lowering the microalbuminuric range may be reinforced. Limitations of the present study could are 1) Small study population who come to the hospital only for an annual medical check up; 2) Difficulty in follow up; 3) Urinary albumin levels were assessed only on a single void urine sample in the present study. Previous studies suggest that urinary albumin levels may exhibit considerable intra individual variations; 4) Hyperlipidemia due to other causes was not excluded.
CONCLUSION
In obesity, which is not complicated by DM and hypertension, urinary albumin levels in the current range of microalbuminuria may not be observed. However, if proper follow up study is carried out on a larger population it may establish a lower reference range and the usefulness of microalbuminuria as a predictor of CVD risk in non-diabetic normotensive obese individuals. 
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